Understanding EPA Registration and Narcotics Decontamination
A Conversation with The Quiet Professional

Recently, SoRite Chief Operating Officer and Legal Counsel Blake Bernard joined The Quiet Professional podcast to discuss a topic that continues to create confusion in the industry: EPA registration and narcotics decontamination claims.

As regulatory oversight increases and marketing language becomes more aggressive across the cleaning and decontamination space, clarity matters. Law enforcement agencies, corrections departments, hazmat teams, and public safety professionals deserve straightforward information about what EPA registration actually means — and what it does not mean.

During the podcast, Blake explained an important distinction.

The Environmental Protection Agency regulates disinfectants under FIFRA when a product makes specific claims about killing bacteria or viruses. Those disinfectant claims must undergo rigorous submission, safety review, and efficacy testing before they can appear on an EPA-registered label.

However, narcotics decontamination is different.

As discussed in the episode, the EPA does not register or approve narcotics decontamination claims. In fact, the agency has made it clear that narcotics decon cannot appear on the same label as a disinfectant claim. The regulatory framework simply does not exist for the EPA to “stamp of approval” narcotics removal or oxidation claims in the same way it does for bacteria and viruses.

That distinction is critical.

A product may be EPA registered — but only for disinfectant purposes. That registration does not extend to fentanyl, methamphetamine, cocaine, or other narcotics decontamination unless explicitly stated, and currently the EPA does not provide that type of claim approval.

Because there is no EPA registration pathway for narcotics decontamination, manufacturers must rely on transparent testing data to support their efficacy claims. That is why SoRite publishes its testing results and provides full documentation on how its formulations perform in controlled environments. Transparency is not optional in this space — it is essential.

As Blake emphasized on the podcast, regulatory compliance is not about finding loopholes. It is about understanding the boundaries of what can legally be claimed, and being upfront about those limitations.

In an environment where fentanyl contamination poses real risks to first responders, corrections officers, hospitality workers, and property managers, education matters as much as innovation.

We appreciate The Quiet Professional for providing a platform to discuss these nuances and to give public safety professionals clearer insight into the regulatory landscape.

You can watch the full conversation here: